Medscape (5/2, Yasgur, Subscription Publication) reports, “A large proportion of US adults who are prescribed Schedule II stimulants are simultaneously receiving other CNS agents including benzodiazepines, opioids, and antidepressants – a potentially dangerous practice,” researchers concluded after analyzing prescription medication “claims for over 9.1 million US adults over a one-year period.” The findings were published online April 24 in BMJ Open.
Related Links:
— MedPage Today (requires login and subscription)